BioCryst: 3Q Earnings Snapshot
DURHAM, N.C. (AP) _ BioCryst Pharmaceuticals Inc. (BCRX) on Tuesday reported a loss of $29.6 million in its third quarter.
On a per-share basis, the Durham, North Carolina-based company said it had a loss of 28 cents.
The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 25 cents per share.
The drugmaker posted revenue of $1.5 million in the period, which also missed Street forecasts. Three analysts surveyed by Zacks expected $2.5 million.
BioCryst shares have increased 62 percent since the beginning of the year. The stock has climbed 69 percent in the last 12 months.